Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.
作者信息
Marino P, Cugno M, Preatoni A, Cori P, Rosti A, Frontini L, Cicardi M
机构信息
Department of Internal Medicine, University of Milan, Italy.
出版信息
Br J Cancer. 1990 Mar;61(3):434-5. doi: 10.1038/bjc.1990.95.
Abstract
摘要
相似文献
1
Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer.肺癌患者血清中可溶性白细胞介素-2受体水平升高。
Br J Cancer. 1990 Mar;61(3):434-5. doi: 10.1038/bjc.1990.95.
2
Elevated serum levels of soluble interleukin-2 receptors in lung cancer and the effect of surgery.
Respir Med. 1993 Jul;87(5):383-5. doi: 10.1016/0954-6111(93)90053-3.
3
Biomarkers and IL-2R in lung cancer.肺癌中的生物标志物与白细胞介素-2受体
Recenti Prog Med. 1990 Nov;81(11):702-4.
4
The clinical significance of serum soluble interleukin-2 receptors in lung cancer.血清可溶性白细胞介素-2受体在肺癌中的临床意义
Lung Cancer. 1996 Aug;15(1):79-84. doi: 10.1016/0169-5002(96)00572-7.
5
Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.肺癌患者血清中白细胞介素-18（IL-18）和可溶性白细胞介素-2受体（sIL-2R）的水平
Rocz Akad Med Bialymst. 2004;49:246-51.
6
Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinoma.小细胞肺癌患者血清中可溶性白细胞介素-2受体水平升高。
J Lab Clin Med. 1990 Oct;116(4):457-61.
7
Prognostic and diagnostic usefulness of serum markers in lung cancer.血清标志物在肺癌中的预后和诊断价值
Eur J Cancer Clin Oncol. 1987 Jul;23(7):893-4. doi: 10.1016/0277-5379(87)90330-0.
8
Serum levels of sFas and sFasL during chemotherapy of lung cancer.肺癌化疗期间血清可溶性Fas及可溶性Fas配体水平
Exp Oncol. 2007 Jun;29(2):132-6.
9
[A study of IL-2 activity on lung cancer].[白细胞介素-2对肺癌作用的研究]
Zhonghua Jie He He Hu Xi Za Zhi. 1991 Aug;14(4):216-8, 255.
引用本文的文献
1
Effect of heavy-ion beam irradiation on the level of serum soluble interleukin-2 receptors in hamster cheek pouch carcinoma model.重离子束照射对仓鼠颊囊癌模型血清可溶性白细胞介素-2受体水平的影响。
Biomed Rep. 2014 May;2(3):408-411. doi: 10.3892/br.2014.238. Epub 2014 Feb 17.
2
Biological significance of soluble IL-2 receptor.可溶性白细胞介素 2 受体的生物学意义。
Mediators Inflamm. 1993;2(1):3-21. doi: 10.1155/S0962935193000018.
3
Adjuvant immunotherapy with intrapleural Streptococcus pyogenes (OK-432) in lung cancer patients after resection.肺癌患者切除术后采用胸膜腔内注射化脓性链球菌（OK-432）进行辅助免疫治疗。
Cancer Immunol Immunother. 1994 Oct;39(4):269-74. doi: 10.1007/BF01525991.
本文引用的文献
1
2
Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.持续输注重组白细胞介素-2在晚期癌症过继性免疫治疗中的应用
N Engl J Med. 1987 Apr 9;316(15):898-905. doi: 10.1056/NEJM198704093161502.
3
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.关于使用淋巴因子激活的杀伤细胞和白细胞介素-2或单独使用高剂量白细胞介素-2治疗157例晚期癌症患者的进展报告。
N Engl J Med. 1987 Apr 9;316(15):889-97. doi: 10.1056/NEJM198704093161501.
4
Increased level of soluble interleukin-2 receptor in advanced solid tumors: a preliminary study.晚期实体瘤中可溶性白细胞介素-2受体水平升高：一项初步研究。
Tumori. 1988 Dec 31;74(6):633-7. doi: 10.1177/030089168807400603.
5
The soluble interleukin-2 receptor in haematological disorders.血液系统疾病中的可溶性白细胞介素-2受体
Br J Haematol. 1987 Dec;67(4):377-80. doi: 10.1111/j.1365-2141.1987.tb06156.x.
6
Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS.可溶性白细胞介素2受体在艾滋病患者或有患艾滋病风险的患者中升高。
Clin Immunol Immunopathol. 1987 Dec;45(3):440-6. doi: 10.1016/0090-1229(87)90095-x.
7
The interleukin 2 receptor. Functional consequences of its bimolecular structure.白细胞介素2受体。其二聚体结构的功能后果。
J Exp Med. 1987 Oct 1;166(4):1055-69. doi: 10.1084/jem.166.4.1055.
8
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.霍奇金病患者血清中的可溶性白细胞介素-2受体
Br J Cancer. 1987 Apr;55(4):427-8. doi: 10.1038/bjc.1987.83.
9
Plasma interleukin 2 receptor levels in renal allograft recipients.
Clin Immunol Immunopathol. 1987 May;43(2):273-6. doi: 10.1016/0090-1229(87)90135-8.
10
The interleukins in acquired disease.后天性疾病中的白细胞介素。
Clin Exp Immunol. 1988 Nov;74(2):151-61.
Zotero 插件